Blog
Discover our latest articles and blogs
Evidence Fusion in PGx: How Labs Combine Sources
Evidence fusion in PGx reporting explained for labs: which sources to combine, how evidence is graded, how conflicts are resolved, and how to keep reports current.
PGx Program Metrics: What Your Lab Should Track and Report
The operational, adoption, and clinical metrics a lab should track for a PGx program, how to model ROI, and how deployment timelines shape what you can measure.
Audit-Ready PGx Reporting: What Your Lab Must Document
What an audit-ready pharmacogenomics report needs: required content, lab documentation, validation, evidence versioning and EHR traceability, with sources.
Consent Management for PGx: A Laboratory Playbook
How laboratories can manage pharmacogenomic consent, retention, withdrawal and secondary use, with a practical consent record model and retention checklist.
Pseudonymization in Genomics: A Practical Guide for Labs
What pseudonymization means for genomic data, how it differs from anonymization under GDPR and HIPAA, and how labs can apply it without losing clinical utility.
Post-Analytic PGx: Reporting, Versioning and Reanalysis
What the post-analytic stage of pharmacogenomic testing covers: report content, sign-out, EHR delivery, versioning and reanalysis, with a template checklist for labs.
Phenoconversion Reporting: How Labs Show Drug-Modified Phenotypes
How clinical labs can report phenoconversion in PGx results: what to show, how to calculate CYP2D6 shifts, and how to avoid alert fatigue in clinical workflows.
RxNorm Mapping for PGx: A Guide for Clinical Labs
How clinical labs map EHR medication products to RxNorm ingredients for PGx reports: term types, pipeline design, version drift and validation.
Polypharmacy PGx Reporting: A Lab Build Guide
How labs can build polypharmacy PGx reporting: medication reconciliation, phenoconversion, actionable alerts, and structured FHIR delivery that prescribers use.